With 80% of clinical trials failing to meet enrollment timelines and up to 50% of sites enrolling one or no patients at all, there are many opportunities to “rescue” studies. When timelines are at risk, data quality is suspect, and management practices are questionable, a new vendor can be brought in to rescue a study and get it back on track.
Download our one-pager for some of the reasons why new vendors step in to rescue studies and a link to our whitepaper on the whole rescue trial process.
.jpg?width=1024&name=business-meeting-picture-id1048663072%20(1).jpg "Group of business people discussing with colleagues on video conference on meeting.")
